Intérêt d’une seconde chirurgie d’exérèse dans les glioblastomes. Étude rétrospective sur quatre ans aux centres hospitalo-universitaires de Montpellier et de Nice et revue de la littérature
Authors:
- 28 February 2010
- journal article
- abstracts
- Published by Elsevier in Neurochirurgie
- Vol. 56 (1) , 36-42
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomasThe Lancet Oncology, 2008
- Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaNeuro-Oncology, 2008
- French brain tumor data bank: Methodology and first results on 10,000 casesJournal of Neuro-Oncology, 2007
- Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastomaNeuro-Oncology, 2005
- Incidence of Central Nervous System Tumors in Gironde, FranceNeuroepidemiology, 2004
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsThe Lancet, 2002
- Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomasBritish Journal of Cancer, 2000
- Survival and Functional Status after Resection of Recurrent Glioblastoma MultiformeNeurosurgery, 1998
- Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomasThe Lancet, 1995
- Reoperation in the Treatment of Recurrent Intracranial Malignant GliomasNeurosurgery, 1987